211 related articles for article (PubMed ID: 26654994)
1. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension.
Jalan R; De Chiara F; Balasubramaniyan V; Andreola F; Khetan V; Malago M; Pinzani M; Mookerjee RP; Rombouts K
J Hepatol; 2016 Apr; 64(4):823-33. PubMed ID: 26654994
[TBL] [Abstract][Full Text] [Related]
2. Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
Jover-Cobos M; Noiret L; Lee K; Sharma V; Habtesion A; Romero-Gomez M; Davies N; Jalan R
J Hepatol; 2014 Mar; 60(3):545-53. PubMed ID: 24512823
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
Vilaseca M; García-Calderó H; Lafoz E; Ruart M; López-Sanjurjo CI; Murphy MP; Deulofeu R; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Liver Int; 2017 Jul; 37(7):1002-1012. PubMed ID: 28371136
[TBL] [Abstract][Full Text] [Related]
4. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
5. Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia.
Dadsetan S; Sørensen M; Bak LK; Vilstrup H; Ott P; Schousboe A; Jalan R; Keiding S; Waagepetersen HS
Biochem Pharmacol; 2013 Jan; 85(1):115-23. PubMed ID: 23103564
[TBL] [Abstract][Full Text] [Related]
6. Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats.
Balasubramaniyan V; Wright G; Sharma V; Davies NA; Sharifi Y; Habtesion A; Mookerjee RP; Jalan R
Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G145-52. PubMed ID: 21903766
[TBL] [Abstract][Full Text] [Related]
7. Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis.
Hennenberg M; Trebicka J; Kohistani Z; Stark C; Nischalke HD; Krämer B; Körner C; Klein S; Granzow M; Fischer HP; Heller J; Sauerbruch T
Lab Invest; 2011 Feb; 91(2):241-51. PubMed ID: 20921950
[TBL] [Abstract][Full Text] [Related]
8. Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide-induced brain edema and coma in cirrhotic rats.
Wright G; Vairappan B; Stadlbauer V; Mookerjee RP; Davies NA; Jalan R
Liver Int; 2012 Mar; 32(3):410-9. PubMed ID: 22151131
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.
Trebicka J; Hennenberg M; Odenthal M; Shir K; Klein S; Granzow M; Vogt A; Dienes HP; Lammert F; Reichen J; Heller J; Sauerbruch T
J Hepatol; 2010 Oct; 53(4):702-12. PubMed ID: 20633948
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution.
De Minicis S; Candelaresi C; Agostinelli L; Taffetani S; Saccomanno S; Rychlicki C; Trozzi L; Marzioni M; Benedetti A; Svegliati-Baroni G
Liver Int; 2012 Nov; 32(10):1574-84. PubMed ID: 22938186
[TBL] [Abstract][Full Text] [Related]
11. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
Vilaseca M; García-Calderó H; Lafoz E; García-Irigoyen O; Avila MA; Reverter JC; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Hepatology; 2017 Jun; 65(6):2031-2044. PubMed ID: 28142199
[TBL] [Abstract][Full Text] [Related]
12. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
13. Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death.
Angelova PR; Kerbert AJC; Habtesion A; Hall A; Abramov AY; Jalan R
JHEP Rep; 2022 Aug; 4(8):100510. PubMed ID: 35845295
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats.
Lin HC; Huang YT; Yang YY; Lee PC; Hwang LH; Lee WP; Kuo YJ; Lee KC; Hsieh YC; Liu RS
J Gastroenterol Hepatol; 2014 May; 29(5):1073-82. PubMed ID: 24325631
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
16. Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure.
Bosoi CR; Yang X; Huynh J; Parent-Robitaille C; Jiang W; Tremblay M; Rose CF
Free Radic Biol Med; 2012 Apr; 52(7):1228-35. PubMed ID: 22300646
[TBL] [Abstract][Full Text] [Related]
17. The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension.
Duong HT; Dong Z; Su L; Boyer C; George J; Davis TP; Wang J
Small; 2015 May; 11(19):2291-304. PubMed ID: 25641921
[TBL] [Abstract][Full Text] [Related]
18. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
19. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.
Davies NA; Wright G; Ytrebø LM; Stadlbauer V; Fuskevåg OM; Zwingmann C; Davies DC; Habtesion A; Hodges SJ; Jalan R
Hepatology; 2009 Jul; 50(1):155-64. PubMed ID: 19437490
[TBL] [Abstract][Full Text] [Related]
20. Blockage of TRPM7 channel induces hepatic stellate cell death through endoplasmic reticulum stress-mediated apoptosis.
Zhu Y; Men R; Wen M; Hu X; Liu X; Yang L
Life Sci; 2014 Jan; 94(1):37-44. PubMed ID: 24220678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
